Numeric Investors’s Corcept Therapeutics CORT Stock Holding History

Numeric Investors’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$5.44M	Sell	301,192 -60,221	-17%	-$1.09M	0.04%	404
2017 Q3	$6.97M	Buy	361,413 +104,300	+41%	+$1.56M	0.05%	324
2017 Q2	$3.03M	Sell	257,113 -118,900	-32%	-$1.29M	0.03%	429
2017 Q1	$4.12M	Buy	376,013 +111,100	+42%	+$976K	0.04%	362
2016 Q4	$1.92M	Buy	264,913 +113,700	+75%	+$891K	0.02%	513
2016 Q3	$983K	Buy	151,213 +58,800	+64%	+$342K	0.01%	623
2016 Q2	$505K	Buy	+92,413	New	+$481K	﹤0.01%	745

Other funds holding CORT

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Numeric Investors's CORT Position: Q4 2017 in Review

Numeric Investors reduced its Corcept Therapeutics (CORT) stake by 17% in Q4 2017, selling an estimated $1.09M and leaving 301,192 shares worth $5.44M. The position accounts for 0.04% of the portfolio, ranked #404.

Numeric Investors first reported a position in CORT in Q2 2016 and has held it in 7 quarters since. The position peaked at $6.97M in Q3 2017. 190 funds tracked by Wall St. Rank hold CORT as of Q4 2017.

Numeric Investors held 301,192 shares of Corcept Therapeutics worth $5.44M as of Q4 2017.
Numeric Investors sold 60,221 Corcept Therapeutics shares in Q4 2017, an estimated $1.09M.
Corcept Therapeutics made up 0.04% of Numeric Investors's portfolio in Q4 2017, its #404 holding.
Numeric Investors first reported a position in Corcept Therapeutics in Q2 2016 and has held it in 7 quarters since.
Numeric Investors's Corcept Therapeutics position peaked at $6.97M in Q3 2017.
190 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.